Combination therapy found safe and beneficial for acute myeloid leukemia patients with specific genetic profile

Updated on: July 14,2025 0

Combination therapy found safe and beneficial for acute myeloid leukemia patients with specific genetic profile

Updated on:July 14,2025 0

More young women are getting breast cancer—why?

Updated on: July 11,2025 0

More young women are getting breast cancer—why?

Updated on:July 11,2025 0

Cervical cancer affects not only women, but also mental health and finances of their family

Updated on: July 13,2025 0

Cervical cancer affects not only women, but also mental health and finances of their family

Updated on:July 13,2025 0

New dual-drug strategy shows promise against aggressive leukemia

Updated on: August 08,2025 0

New dual-drug strategy shows promise against aggressive leukemia

Updated on:August 08,2025 0

Discovery of a new biomarker for early detection of bladder cancer in both dogs and humans

Updated on: October 06,2025 0

Discovery of a new biomarker for early detection of bladder cancer in both dogs and humans

Updated on:October 06,2025 0

Metabolism linked to protective effect of breastfeeding against breast cancer

Updated on: August 13,2025 0

Metabolism linked to protective effect of breastfeeding against breast cancer

Updated on:August 13,2025 0

Novel assay promises more efficient screening for carriers of fragile X syndrome

Updated on: July 10,2025 0

Novel assay promises more efficient screening for carriers of fragile X syndrome

Updated on:July 10,2025 0

Ketamine use in chronic pain unsupported by evidence, review finds

Updated on: September 03,2025 0

Ketamine use in chronic pain unsupported by evidence, review finds

Updated on:September 03,2025 0

First-in-human trial shows promising results for antibody-drug conjugate in relapsed small cell lung cancer

Updated on: October 05,2025 0

First-in-human trial shows promising results for antibody-drug conjugate in relapsed small cell lung cancer

Updated on:October 05,2025 0

No OS benefit for concurrent and consolidative durvalumab vs. consolidation alone in unresectable stage 3 NSCLC: Trial

Updated on: October 05,2025 0

No OS benefit for concurrent and consolidative durvalumab vs. consolidation alone in unresectable stage 3 NSCLC: Trial

Updated on:October 05,2025 0